Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice

Heidi D. Finnes, Kari G. Chaffee, Timothy G. Call, Wei Ding, Saad S. Kenderian, Deborah A. Bowen, Michael Conte, Kristen B. McCullough, Julianna A. Merten, Gabriel T. Bartoo, Matthew D. Smith, Jose Leis, Asher Chanan-Khan, Susan M. Schwager, Susan L. Slager, Neil E. Kay, Tait D. Shanafelt, Sameer A. Parikh

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice'. Together they form a unique fingerprint.

Medicine & Life Sciences